niacinamide has been researched along with ps1145 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, PJ; Catley, MC; Holden, NS; Leigh, R; Newton, R; Oyelusi, W; Proud, D | 1 |
Koetzler, R; Newton, R; Proud, D; Zaheer, RS | 1 |
2 other study(ies) available for niacinamide and ps1145
Article | Year |
---|---|
Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors.
Topics: Carbolines; Cells, Cultured; Cytokines; Epithelial Cells; Gene Expression Regulation; Heterocyclic Compounds, 3-Ring; Humans; I-kappa B Kinase; Interleukin-1beta; Interleukin-6; Interleukin-8; Lung; NF-kappa B; Niacinamide; Protein Kinase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyridines; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2007 |
Nitric oxide inhibits IFN regulatory factor 1 and nuclear factor-kappaB pathways in rhinovirus-infected epithelial cells.
Topics: Carbolines; Cells, Cultured; Chemokine CXCL10; Epithelial Cells; Heterocyclic Compounds, 3-Ring; Humans; I-kappa B Kinase; Interferon Regulatory Factor-1; NF-kappa B; Niacinamide; Nitric Oxide; Nitric Oxide Donors; Picornaviridae Infections; Pyridines; Rhinovirus | 2009 |